Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 219.00
Bid: 220.00
Ask: 221.00
Change: 4.00 (1.86%)
Spread: 1.00 (0.455%)
Open: 214.00
High: 220.50
Low: 214.00
Prev. Close: 215.00
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

6 Nov 2015 07:00

RNS Number : 7856E
Tullett Prebon PLC
06 November 2015
 



6 November 2015

Tullett Prebon plc

Trading Statement

Tullett Prebon plc (the "Company") is today issuing a trading update in relation to the period from 1 July 2015.

 

Business Update

 

Our strategic review, the results of which were communicated to the market in June this year, concluded that the central role played by interdealer brokers at the heart of the global wholesale OTC markets remains secure, but that revenue declines were likely to continue in a number of traditional interdealer broker products.

 

Over the summer and through September and October the level of activity in the wholesale OTC financial markets has continued to be under pressure from the structural and cyclical factors affecting the interdealer broker industry. Market volumes continue to be adversely affected by the more onerous regulatory environment applicable to many of our bank customers whose trading activity has been suppressed by the deleveraging of their balance sheets and lower risk appetite. The continuation of low interest rate conditions and compressed bond market spreads in Europe has further dampened activity, particularly in Interest Rate Derivatives and Fixed Income products.

 

The strategic review concluded that the Energy and commodities markets do not currently face all the same pressures as the traditional interdealer broker product areas, and we have continued to benefit from the investments we have made in this sector. The performance of PVM Oil Associates Limited and its subsidiaries ("PVM"), which was acquired in November last year, has continued to be strong. PVM's main activities are in crude oil and petroleum products, and the business has continued to benefit from the level of activity in the oil and related products markets, which picked up following the significant changes in the oil price experienced since the start of the second half of 2014.

 

Revenue in the four months July to October of £255m was 9% higher than the £233m reported for the same period last year. Excluding PVM, revenue in the four months July to October was 5% lower at constant exchange rates than in the same period last year.

 

Year to date (January to October) revenue of £671m was 13% higher than the £594m reported for the same period last year. Excluding PVM, year to date revenue was 3% lower at constant exchange rates than in the same period last year.

 

We have continued to invest in the business's capabilities to identify and implement business initiatives. We have also continued to roll out our cultural, legal, compliance and risk governance frameworks to deliver our commitment to instil and embed the highest standards of conduct. As set out in our interim results announcement, these investments, increasing regulatory related costs, and the impact of the areas of business weakness, are expected to offset the improvement in the operating margin compared with that delivered last year. The further decline in revenue during the second half puts further pressure on the operating margin. The 2015 full year underlying operating profit margin is now expected to be approximately 1.5% points lower than last year.

 

In the light of the further reduction in market volumes since the end of June, particularly in Europe, further action is being taken to reduce headcount and fixed costs in the affected areas. These actions are expected to result in a reduction of around 5% in the front office headcount in the traditional interdealer product areas. The cost of these actions will be charged as an exceptional item in the 2015 accounts.

 

The Company was voted the number one interdealer broker in Currency in Risk magazine's 2015 annual interdealer rankings published in September, and was named Interest Rates Broker of the Year, and SEF of the Year, in the 2015 GlobalCapital awards.

 

The Company's financial position remains strong.

 

 

Enquiries:

 

 

Paul Mainwaring

Finance Director, Tullett Prebon plc

Direct: +44 (0)20 7200 7995

Email: pmainwaring@tullettprebon.com

 

Stephen Breslin

Group Head of Communications, Tullett Prebon plc

Direct: +44(0)20 7200 7750

Email: sbreslin@tullettprebon.com

 

Craig Breheny

Brunswick Group LLP

Direct: +44(0)20 7396 7429

Email: cbreheny@brunswickgroup.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBELLBEFFZFBB
Date   Source Headline
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20216:15 pmRNSDirector/PDMR Shareholding
26th Mar 20212:05 pmRNSAnnual Financial Report
10th Mar 20215:16 pmRNSRe-registration and name change
9th Mar 20217:03 amRNSFinal Results
26th Feb 20218:24 amRNSScheme Effective and Admission
24th Feb 20214:24 pmRNSCourt Sanction of the Scheme of Arrangement
18th Feb 20214:20 pmRNSHolding(s) in Company
17th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Feb 20214:00 pmRNSTotal Voting Rights
17th Feb 202111:12 amRNSResults of Rump Placing
17th Feb 20217:00 amRNSResults of Rights Issue
16th Feb 20212:56 pmRNSHolding(s) in Company
2nd Feb 20218:00 amRNSAdmission of Nil Paid Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.